18 studies found for:    therapeutic vaccine | Open Studies | HIV
Show Display Options
RSS Create an RSS feed from your search for:
therapeutic vaccine | Open Studies | HIV
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Representations and Acceptability of HIV Therapeutic Vaccine in a Cohort of HIV-1 Infected Outpatients Followed at Hospital
Condition: HIV
Interventions: Other: Questionnaire;   Other: Interview
2 Recruiting Therapeutic Vaccine for HIV
Conditions: HIV;   Therapeutic Vaccine
Interventions: Biological: HIV-1 Multiantigen pDNA Vaccine;   Biological: Human IL-12 pDNA;   Procedure: In Vivo Electroporation using the TriGri;   Biological: rVSVIN HIV Gag Vaccine;   Biological: Placebo
3 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution;   Biological: Saline solution
4 Recruiting Safety and Efficacy of the Histone Deacetylase Inhibitor Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV‐1 Reservoir
Condition: Chronic HIV-infection
Interventions: Drug: Romidepsin (Istodax®);   Biological: Vacc-4x;   Biological: rhuGM-CSF (Leukine®)
5 Not yet recruiting Poly-ICLC in Treated HIV Infection
Condition: HIV-1 Infected Adults With Chronic HIV-1 Infection
Intervention: Drug: Poly-ICLC
6 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
7 Recruiting Lipopeptide Immunisation With GTU-multiHIV Trial
Condition: HIV-1 Infection
Interventions: Biological: Placebos of GTU-multiHIV B and LIPO-5 vaccines;   Biological: GTU-multHIV B vaccine and LIPO-5 vaccine
8 Recruiting Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard ART in the Course of HIV-1 Infection
Condition: HIV
Intervention: Biological: VAC-3S
9 Recruiting Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Saline Solution;   Biological: D-GPEi;   Biological: M-GPE
10 Unknown  EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine
Condition: HIV
Interventions: Biological: EN41-FPA2 HIV vaccine;   Biological: Na Cl Placebo vaccine
11 Not yet recruiting Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine
Condition: - HIV
Interventions: Biological: EN41-UGR7C HIV vaccine;   Biological: NaCl
12 Recruiting Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002
Condition: HIV Infection
Intervention: Other: No intervention
13 Recruiting Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients
Condition: HIV
Intervention: Drug: Etoricoxib
14 Recruiting Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)
Condition: HIV-1 Infection
Interventions: Drug: Part A: lenalidomide dose escalation;   Drug: Part B: lenalidomide;   Drug: Part B: lenalidomide placebo
15 Recruiting Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Raltegravir
16 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
Condition: HIV Infections
Interventions: Drug: lopinavir;   Drug: atazanavir;   Drug: efavirenz;   Drug: fosamprenavir;   Drug: darunavir;   Drug: tipranavir;   Drug: ritonavir;   Drug: nevirapine;   Drug: zidovudine;   Drug: lamivudine;   Drug: tenofovir;   Drug: emtricitabine;   Drug: abacavir
17 Recruiting Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Condition: Sarcoma, Kaposi
Interventions: Drug: Liposomal Doxorubicin;   Drug: Bevacizumab
18 Unknown  Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn
Conditions: Infant, Newborn, Diseases;   Sepsis;   Puerperal Infection
Interventions: Drug: Chlorhexidine;   Procedure: Birth canal wipe;   Procedure: sterile water external genital wipe

Indicates status has not been verified in more than two years